The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Scientists Pinpoint Three HLA Proteins Linked to Seropositive Rheumatoid Arthritis

Scientists Pinpoint Three HLA Proteins Linked to Seropositive Rheumatoid Arthritis

February 28, 2012 • By Carrie Printz

  • Tweet
  • Email
Print-Friendly Version / Save PDF

You Might Also Like
  • Genetic Risk Factors for Rheumatoid Arthritis Merit More Research
  • 2013 ACR/ARHP Annual Meeting: Genetic Research Yields Clues to Pathogenesis of Rheumatoid Arthritis, Psoriatic Arthritis
  • Study Shows Rheumatoid Arthritis Linked to Atrial Fibrillation
Three-dimensional ribbon models for the HLA-DR, HLA-B, and HLA-DP proteins.
click for large version

Researchers have identified five amino acids in three HLA proteins that explain most of the association between major histocompatibility complex (MHC) and seropositive rheumatoid arthritis (RA).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“About one third of the genetic risk for the disease comes from MHC—and most of that comes from three separate proteins,” says Soumya Raychaudhuri, MD, PhD, assistant professor with the divisions of rheumatology and genetics at Brigham and Women’s Hospital and Harvard Medical School in Boston. “We all understood DRB1 as a risk-conferring molecule, and now we know that HLA-B and HLA-DPB1 also play a role.”

Dr. Raychaudhuri is the lead author of the study, which was published online Jan. 29 in Nature Genetics.1 He, colleague Paul de Bakker, PhD, and others found that most of the genetic risk comes from differences in the antigen binding sites of those molecules.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“The hope is that studies such as these will help us understand which key autoantigens people are responding to,” he says. “The antigen for rheumatoid arthritis never has been easy to define.”

The strong association with MHC was first determined in the 1970s. The evidence that this association was potentially related to antigen binding was later demonstrated by the shared epitope hypotheses, first put forth in 1987 by Peter K. Gregersen, MD, Jack Silver, PhD, and Robert J. Winchester, MD.2 Despite serving as the foundation for genetic studies for RA, the shared epitope hypothesis did not fully explain the association at HLA-DRB1.

The new study builds on the shared epitope hypothesis and pins down the specific position in the molecule to which the antigen is binding, Dr. Raychaudhuri says.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“Our studies are much larger, and the genotyping and statistical analysis have advanced a lot,” he adds. “All of these things have made this study possible in a way that wouldn’t have been possible 20 years ago.”

Their results have predictive value in defining people’s relative risks for RA. However, one of the challenges of developing a genetic test for a disease is that it must be highly predictive, Dr. Raychaudhuri says.

He cites as an example that individuals who might have the greatest risk-conferring alleles at HLA-DRB1 association in both chromosomes have roughly a 15- to 20-fold risk of RA over the general population. But, since the risk of the disease in the general population is only 0.5%, such individuals would only have a 10% risk of seropositive RA.

“For the average person walking in off the street without any symptoms, this may not predict they’ll get the disease,” Dr. Raychaudhuri says. “But if there’s an ambiguous diagnosis, it could certainly add information.”

The next step for researchers is to understand the antigen that triggers the immune response and how it might interact with the different receptors that cause the disease. Finding a way to alter that interaction could be a potential avenue for therapy, he says.

 


Carrie Printz is a medical journalist based in Denver.

References

1. Raychaudhuri S, Sandor C, Stahl EA, et. al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet. 2012 Jan 29. doi: 10.1038/ng.1076. [Epub ahead of print]

2. Gregerson PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 2005;30:1205-1213.

Pages: 1 2 | Multi-Page

Filed Under: Conditions, Research Reviews, Rheumatoid Arthritis Tagged With: Arthritis, Biomarkers, RA

You Might Also Like:
  • Genetic Risk Factors for Rheumatoid Arthritis Merit More Research
  • 2013 ACR/ARHP Annual Meeting: Genetic Research Yields Clues to Pathogenesis of Rheumatoid Arthritis, Psoriatic Arthritis
  • Study Shows Rheumatoid Arthritis Linked to Atrial Fibrillation
  • Gene to Block TNF Linked to Multiple Sclerosis but not Rheumatoid Arthritis

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.